Efficacy of Fluvoxamine versus Placebo for Outpatients with COVID-19: A Systematic Review and Meta-Analysis

被引：0
|
作者：
Bhuta, S. [1 ]
Patel, N. J. [1 ]
Khokher, W. [1 ]
Kesireddy, N. [1 ]
Patel, M. [1 ]
Burmeister, C. [1 ]
Ghazaleh, S. [1 ]
Assaly, R. [1 ]
机构：
[1] Univ Toledo, Internal Med, 2801 W Bancroft St, Toledo, OH 43606 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3142
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of fluvoxamine for the treatment of COVID-19 patients: A systematic review and meta-analysis
    Cheema, Huzaifa Ahmad
    Jafar, Uzair
    Elrashedy, Asmaa Ahmed
    Shahid, Abia
    Awan, Rehmat Ullah
    Ehsan, Muhammad
    Ayyan, Muhammad
    Sahra, Syeda
    [J]. JOURNAL OF INFECTION, 2022, 85 (06) : 720 - 723
  • [2] Thromboprophylaxis for outpatients with COVID-19: a Systematic Review and Meta-analysis
    Chiang, Cho-Han
    Ahmed, Omer
    Liu, Weitao
    See, Xin Ya
    Chang, Yu-Cheng
    Peng, Chun-Yu
    Wang, Zihan
    Chiang, Cho-Hsien
    Hsia, Yuan Ping
    Chiang, Cho-Hung
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (05) : 784 - 787
  • [3] Safety and efficacy of antithrombotics in outpatients with symptomatic COVID-19: A systematic review and meta-analysis
    Ansari, Saad Ali
    Merza, Nooraldin
    Salman, Madiha
    Raja, Adarsh
    Sayeed, Bushra Zafar
    Rahman, Hafsah Alim Ur
    Bhimani, Sunaina
    Shaikh, Afrah Saeed
    Naqi, Unaiza
    Farooqui, Areeba
    Afridi, Simra
    Feroze, Ahsan
    Hameed, Ishaque
    [J]. CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (04)
  • [4] Evaluating fluvoxamine for the outpatient treatment of COVID-19: A systematic review and meta-analysis
    Deng, Jiawen
    Moskalyk, Myron
    Zuo, Qi Kang
    Garcia, Cristian
    Abbas, Umaima
    Ramaraju, Harikrishnaa Ba
    Rayner, Daniel
    Park, Ye-Jean
    Heybati, Kiyan
    Zhou, Fangwen
    Lohit, Simran
    [J]. REVIEWS IN MEDICAL VIROLOGY, 2024, 34 (01)
  • [5] Efficacy of tocilizumab in COVID-19: A systematic review and meta-analysis
    Aziz, Muhammad
    Haghbin, Hossein
    Abu Sitta, Emad
    Nawras, Yusuf
    Fatima, Rawish
    Sharma, Sachit
    Lee-Smith, Wade
    Duggan, Joan
    Kammeyer, Joel A.
    Hanrahan, Jennifer
    Assaly, Ragheb
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (03) : 1620 - 1630
  • [6] Efficacy and Safety of Fluvoxamine as Outpatient Treatment for Patients With Covid-19: A Systematic Review and Meta-analysis of Clinical Trials
    Vatvani, Akhil Deepak
    Kurniawan, Andree
    Hariyanto, Timotius Ivan
    [J]. ANNALS OF PHARMACOTHERAPY, 2023, 57 (12) : 1389 - 1397
  • [7] The efficacy and safety of fluvoxamine in patients with COVID-19: A systematic review and meta-analysis from randomized controlled trials
    Zhou, Qiufeng
    Zhao, Guozheng
    Pan, Yu
    Zhang, Ying
    Ni, Yuehua
    [J]. PLOS ONE, 2024, 19 (05):
  • [8] Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization A Systematic Review and Meta-analysis
    Lee, Todd C.
    Vigod, Simone
    Bortolussi-Courval, Emilie
    Hanula, Ryan
    Boulware, David R.
    Lenze, Eric J.
    Reiersen, Angela M.
    McDonald, Emily G.
    [J]. JAMA NETWORK OPEN, 2022, 5 (04) : E226269
  • [9] Efficacy and safety of antiviral treatments for symptomatic COVID-19 outpatients: Systematic review and network meta-analysis
    Zur, Meital
    Peselev, Thalia
    Yanko, Stav
    Rotshild, Victoria
    Matok, Ilan
    [J]. ANTIVIRAL RESEARCH, 2024, 221
  • [10] Effect of fluvoxamine on outcomes of nonhospitalized patients with COVID-19: A systematic review and meta-analysis
    Lu, Li-Chin
    Chao, Chien-Ming
    Chang, Shen-Peng
    Lan, Shao-Huan
    Lai, Chih-Cheng
    [J]. JOURNAL OF INFECTION AND PUBLIC HEALTH, 2022, 15 (11) : 1259 - 1264
12345